Search

everythinglearnresearchcommunity

for

Search:↓

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Interface dermatitis is the most common skin change in drug-induced hypersensitivity syndrome.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Frequent hairdryer use may worsen hair fragility in people with Pili Annulati.

An infant with Hutchinson-Gilford Progeria Syndrome had successful surgery to fix breathing issues caused by a new genetic mutation.

Eyelash loss can be a sign of thyroid problems.

Tryushana Churna and Kanchanara Guggulu may help improve hypothyroidism symptoms.

More men have androgenic alopecia than women, with stress linked to the condition in both genders.

Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.

Non-ablative Er:YAG-laser treatment helps improve life quality for menopausal women with hair loss.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Androgenetic alopecia is linked to higher cholesterol in both sexes and obesity in women.

Mixing equal parts of honey and ghee is harmful.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

The 'Swiss cheese' pattern in scalp biopsies can indicate trichotillomania, not just alopecia areata.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Generalized trichoepitheliomas with alopecia may indicate myasthenia gravis.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

CTE can distort results in hair growth trials, so exclude it carefully.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Gomez–Lopez–Hernandez syndrome can cause focal hair loss and developmental delays but some children can still function well and excel in school and sports.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.